Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chie Honma"'
Autor:
Atsuto, Mouri, Yoichiro, Hamamoto, Nobuhisa, Kameyama, Tatsuya, Ibe, Shinjiro, Takeoka, Chie, Honma, Munehisa, Fukusumi, Mitsuhiro, Kamimura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(9)
S-1 is one of the effective chemotherapy regimens for treating non-small cell lung cancer. We report of an elderly patient with non-small cell lung cancer who responded to S-1 monotherapy following gefitinib therapy. An 83-year-old woman was diagnose
Autor:
Atsuto Mouri, Kazushige Wakuda, Mitsuhiro Kamimura, Tatsuya Ibe, Miyuki Wagatsuma, Akito Tashiro, Yoichiro Hamamoto, Yoshihito Arimoto, Kazuaki Yamada, Chie Honma, Munehisa Fukusumi, Shingo Kamoshida, Takeoka Shinjiro
Publikováno v:
Journal of Thoracic Oncology. 12:S1360
Autor:
Yoichiro Hamamoto, Yoshihito Arimoto, Shinjiro Takeoka, Kazushige Wakuda, Atsuto Mouri, Munehisa Fukusumi, Miyuki Wagatsuma, Tatsuya Ibe, Mitsuhiro Kamimura, Akito Tashiro, Chie Honma, Kazuaki Yamada, Shingo Kamoshida
Publikováno v:
Rare Diseases
Objective: Malignant pleural mesothelioma (MPM) is a rare and aggressive, treatment-resistant cancer. Pemetrexed, an inhibitor of thymidylate synthase (TS), is used worldwide for MPM as a first-line chemotherapy regimen. However, there is little cons